• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SERINC5通过干扰乙肝病毒包膜的糖基化来抑制完整和无基因组乙肝病毒颗粒的分泌。

SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.

作者信息

Liu Yue, Wang Hong, Zhang Jun, Yang Jing, Bai Lu, Zheng Baisong, Zheng Tianhang, Wang Yingchao, Li Jianhua, Zhang Wenyan

机构信息

Institute of Virology and AIDS Research, The First Hospital of Jilin University, Changchun, China.

Department of Echocardiography, The First Hospital of Jilin University, Changchun, China.

出版信息

Front Microbiol. 2020 Apr 30;11:697. doi: 10.3389/fmicb.2020.00697. eCollection 2020.

DOI:10.3389/fmicb.2020.00697
PMID:32431673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7216740/
Abstract

Serine incorporator 3 (SERINC3) and SERINC5 were recently identified as host intrinsic factors against human immunodeficiency virus (HIV)-1 and counteracted by HIV-1 Nef. However, whether they inhibit hepatitis B virus (HBV), which is a severe health problem worldwide, is unknown. Here, we demonstrate that SERINC5 potently inhibited HBV virion secretion in the supernatant without affecting intracellular core particle-associated DNA and the total RNA, but SERINC3 and SERINC1 did not. Further investigation discovered that SERINC5 increased the non-glycosylation of LHB, MHB, and SHB proteins of HBV and slightly decreased HBs proteins levels, which led to the decreased HBV secretion. Importantly, SERINC5 co-localized with LHB proteins in the Golgi apparatus, which is important for glycan processing and transport. In addition, we determined the functional domain in SERINC5 required for HBV inhibition, which was completely different from that required for HIV-1 restriction, whereas phosphorylation and glycosylation sites in SERINC5 were dispensable for HBV restriction. Taken together, our results demonstrate that SERINC5 suppresses HBV virion secretion through interfering with the glycosylation of HBV proteins, suggesting that SERINC5 might possess broad-spectrum antiviral activity.

摘要

丝氨酸整合蛋白3(SERINC3)和SERINC5最近被鉴定为针对人类免疫缺陷病毒1型(HIV-1)的宿主内在因子,并被HIV-1 Nef蛋白所拮抗。然而,它们是否抑制乙型肝炎病毒(HBV)(这是一个全球范围内严重的健康问题)尚不清楚。在此,我们证明SERINC5能有效抑制上清液中HBV病毒粒子的分泌,而不影响细胞内核心颗粒相关的DNA和总RNA,但SERINC3和SERINC1则无此作用。进一步研究发现,SERINC5增加了HBV的大蛋白(LHB)、中蛋白(MHB)和小蛋白(SHB)的非糖基化,并略微降低了表面抗原蛋白(HBs)水平,从而导致HBV分泌减少。重要的是,SERINC5与LHB蛋白在高尔基体中共定位,高尔基体对聚糖加工和转运很重要。此外,我们确定了SERINC5中抑制HBV所需的功能结构域,这与限制HIV-1所需的结构域完全不同,而SERINC5中的磷酸化和糖基化位点对于抑制HBV是可有可无的。综上所述,我们的结果表明,SERINC5通过干扰HBV蛋白的糖基化来抑制HBV病毒粒子的分泌,这表明SERINC5可能具有广谱抗病毒活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/b0e8c34c703e/fmicb-11-00697-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/1b22e6a7d30f/fmicb-11-00697-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/364ee59895e9/fmicb-11-00697-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/f33ab4bc4410/fmicb-11-00697-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/232b4f165745/fmicb-11-00697-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/4d5d4d599cd5/fmicb-11-00697-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/84af67097ee3/fmicb-11-00697-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/21abd5ae1f2a/fmicb-11-00697-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/b0e8c34c703e/fmicb-11-00697-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/1b22e6a7d30f/fmicb-11-00697-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/364ee59895e9/fmicb-11-00697-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/f33ab4bc4410/fmicb-11-00697-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/232b4f165745/fmicb-11-00697-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/4d5d4d599cd5/fmicb-11-00697-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/84af67097ee3/fmicb-11-00697-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/21abd5ae1f2a/fmicb-11-00697-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57ad/7216740/b0e8c34c703e/fmicb-11-00697-g008.jpg

相似文献

1
SERINC5 Inhibits the Secretion of Complete and Genome-Free Hepatitis B Virions Through Interfering With the Glycosylation of the HBV Envelope.SERINC5通过干扰乙肝病毒包膜的糖基化来抑制完整和无基因组乙肝病毒颗粒的分泌。
Front Microbiol. 2020 Apr 30;11:697. doi: 10.3389/fmicb.2020.00697. eCollection 2020.
2
The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.HIV-1 Nef对SERINC5颗粒感染性限制的拮抗作用涉及限制因子病毒体相关库的反作用。
J Virol. 2016 Nov 14;90(23):10915-10927. doi: 10.1128/JVI.01246-16. Print 2016 Dec 1.
3
SERINC5 Potently Restricts Retrovirus Infection .SERINC5 强效限制逆转录病毒感染。
mBio. 2020 Jul 14;11(4):e00588-20. doi: 10.1128/mBio.00588-20.
4
Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.Nef 蛋白在没有 SERINC3 和 SERINC5 的情况下可显著增强 HIV-1 的复制。
mBio. 2019 Jun 11;10(3):e01071-19. doi: 10.1128/mBio.01071-19.
5
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.SERINC3和SERINC5限制HIV-1的感染性,并被Nef蛋白拮抗。
Nature. 2015 Oct 8;526(7572):218-23. doi: 10.1038/nature15400. Epub 2015 Sep 30.
6
An N-Glycosylated Form of SERINC5 Is Specifically Incorporated into HIV-1 Virions.一种 N-糖基化形式的 SERINC5 特异性地被掺入 HIV-1 病毒粒子中。
J Virol. 2018 Oct 29;92(22). doi: 10.1128/JVI.00753-18. Print 2018 Nov 15.
7
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles.宿主细胞限制因子SERINC5可限制HIV-1的感染性,而不改变病毒颗粒的脂质组成和结构。
J Biol Chem. 2017 Aug 18;292(33):13702-13713. doi: 10.1074/jbc.M117.797332. Epub 2017 Jun 28.
8
Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor.聚焦HIV-1 Nef:SERINC3和SERINC5被确定为受致病因子拮抗的限制因子。
Viruses. 2015 Dec 19;7(12):6730-8. doi: 10.3390/v7122970.
9
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists.啮齿动物和兔 SERINC3 和 SERINC5 的抗病毒活性可被已知的病毒拮抗剂所拮抗。
J Gen Virol. 2019 Feb;100(2):278-288. doi: 10.1099/jgv.0.001201. Epub 2018 Dec 19.
10
Differential Pressures of SERINC5 and IFITM3 on HIV-1 Envelope Glycoprotein over the Course of HIV-1 Infection.HIV-1感染过程中SERINC5和IFITM3对HIV-1包膜糖蛋白的压差
J Virol. 2020 Jul 30;94(16). doi: 10.1128/JVI.00514-20.

引用本文的文献

1
SERINC5 counters retroviruses and non-retroviruses.SERINC5可对抗逆转录病毒和非逆转录病毒。
Front Cell Infect Microbiol. 2025 Jan 20;14:1516806. doi: 10.3389/fcimb.2024.1516806. eCollection 2024.
2
HIV-1 and BLV are insensitive to SERINC5 restriction under the cell-cell infection.在细胞间感染情况下,HIV-1和BLV对SERINC5限制不敏感。
Microbiol Spectr. 2025 Mar 4;13(3):e0274824. doi: 10.1128/spectrum.02748-24. Epub 2025 Jan 27.
3
In vitro and in silico analyses of amino acid substitution effects at the conserved N-linked glycosylation site in hepatitis B virus surface protein on antigenicity, immunogenicity, HBV replication and secretion.

本文引用的文献

1
Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.Nef 蛋白在没有 SERINC3 和 SERINC5 的情况下可显著增强 HIV-1 的复制。
mBio. 2019 Jun 11;10(3):e01071-19. doi: 10.1128/mBio.01071-19.
2
CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.CD4 表达和Env 构象对于 SERINC5 限制 HIV-1 至关重要。
J Virol. 2019 Jun 28;93(14). doi: 10.1128/JVI.00544-19. Print 2019 Jul 15.
3
Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G.
乙型肝炎病毒表面蛋白保守N-糖基化位点氨基酸取代对其抗原性、免疫原性、乙肝病毒复制及分泌影响的体外和计算机模拟分析
PLoS One. 2025 Jan 6;20(1):e0316328. doi: 10.1371/journal.pone.0316328. eCollection 2025.
4
The host restriction factor SERINC5 inhibits HIV-1 transcription by negatively regulating NF-κB signaling.宿主限制因子SERINC5通过负向调节核因子κB信号通路来抑制HIV-1转录。
J Biol Chem. 2025 Jan;301(1):108058. doi: 10.1016/j.jbc.2024.108058. Epub 2024 Dec 7.
5
Intracellular Host Restriction of Hepatitis B Virus Replication.乙型肝炎病毒复制的细胞内宿主限制。
Viruses. 2024 May 11;16(5):764. doi: 10.3390/v16050764.
6
Disruption of Transmembrane Phosphatidylserine Asymmetry by HIV-1 Incorporated SERINC5 Is Not Responsible for Virus Restriction.HIV-1 整合的 SERINC5 破坏跨膜磷脂酰丝氨酸不对称性,但与病毒限制无关。
Biomolecules. 2024 May 10;14(5):570. doi: 10.3390/biom14050570.
7
Beyond Impairment of Virion Infectivity: New Activities of the Anti-HIV Host Cell Factor SERINC5.超越病毒感染力损伤:抗 HIV 宿主细胞因子 SERINC5 的新活性。
Viruses. 2024 Feb 12;16(2):284. doi: 10.3390/v16020284.
8
The Antiviral Factor SERINC5 Impairs the Expression of Non-Self-DNA.抗病毒因子 SERINC5 会损害非自身 DNA 的表达。
Viruses. 2023 Sep 20;15(9):1961. doi: 10.3390/v15091961.
9
Host cell restriction factors of equine infectious anemia virus.马传染性贫血病毒的宿主细胞限制因子。
Virol Sin. 2023 Aug;38(4):485-496. doi: 10.1016/j.virs.2023.07.001. Epub 2023 Jul 5.
10
SERINC5 Mediates a Postintegration Block to HIV-1 Gene Expression in Macrophages.SERINC5 对巨噬细胞中 HIV-1 基因表达具有整合后阻断作用。
mBio. 2023 Apr 25;14(2):e0016623. doi: 10.1128/mbio.00166-23. Epub 2023 Mar 28.
肠道病毒 71 拮抗宿主固有抗病毒因子 A3G 的抑制作用。
Nucleic Acids Res. 2018 Nov 30;46(21):11514-11527. doi: 10.1093/nar/gky840.
4
An N-Glycosylated Form of SERINC5 Is Specifically Incorporated into HIV-1 Virions.一种 N-糖基化形式的 SERINC5 特异性地被掺入 HIV-1 病毒粒子中。
J Virol. 2018 Oct 29;92(22). doi: 10.1128/JVI.00753-18. Print 2018 Nov 15.
5
SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue.SIVcol Nef 通过促进 SERINC5 的蛋白酶体降解来拮抗 SERINC5,但不能有效地增强人类 CD4+T 细胞和淋巴组织中的 HIV-1 复制。
PLoS Pathog. 2018 Aug 20;14(8):e1007269. doi: 10.1371/journal.ppat.1007269. eCollection 2018 Aug.
6
The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein.丙型肝炎病毒E2包膜糖蛋白的中和面
Front Immunol. 2018 Jun 11;9:1315. doi: 10.3389/fimmu.2018.01315. eCollection 2018.
7
Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.完整和无基因组乙型肝炎病毒粒子分泌的常见和独特衣壳及表面蛋白需求。
J Virol. 2018 Jun 29;92(14). doi: 10.1128/JVI.00272-18. Print 2018 Jul 15.
8
Impact of immune escape mutations and N-linked glycosylation on the secretion of hepatitis B virus virions and subviral particles: Role of the small envelope protein.免疫逃逸突变和 N -linked 糖基化对乙型肝炎病毒病毒粒子和亚病毒颗粒分泌的影响:小包膜蛋白的作用。
Virology. 2018 May;518:358-368. doi: 10.1016/j.virol.2018.03.011. Epub 2018 Mar 28.
9
HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.HIV-1 Nef 通过内体/溶酶体系统下调 SERINC5 拮抗 SERINC5 的限制。
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00196-18. Print 2018 Jun 1.
10
Novel host restriction factors implicated in HIV-1 replication.新型宿主限制因子与 HIV-1 复制有关。
J Gen Virol. 2018 Apr;99(4):435-446. doi: 10.1099/jgv.0.001026. Epub 2018 Feb 19.